Effect of Altitude on Iron Absorption in Iron Depleted Women
PotatoAlt
1 other identifier
interventional
80
1 country
2
Brief Summary
One of the most common nutritional deficiencies worldwide is iron deficiency. Iron deficiency is considered the main cause of anaemia in developing countries, including those in South America. The most recent surveys report that the prevalence of anaemia is as high as, 40 and 25% in Peru. Populations living at higher altitudes may have higher iron requirements, as body iron is naturally increased in long-term high-altitude residents to compensate for the lower oxygen in the air at high altitudes. However, the effects of chronic exposure to high altitude on iron status, body iron compartments and dietary iron requirements are incompletely understood. The primary objective of the proposed research is to determine iron bioavailability of iron from biofortified potatoes at different altitudes in populations of Andean descent. Human trials will be undertaken with volunteers in the Huancavelica region of Peru (elevation: 3676 meters) as well as in Lima (elevation close to sea level). The aim is to assess the effect of altitude on the absorption from a promising iron biofortified potato cultivar. These trials require incorporation of iron stable isotopes into the meals of the bio fortified potato and the analysis of the isotopes in subsequent blood (red blood cells) samples. Stable iron istotopes are considered the golden standard to assess human iron absorption and can be safely used as tracer substances in humans. The objective of the study is to compare, in volunteer females of childbearing age, the bioavailability of iron from bio-fortified potatoes in two locations of different altitudes and quantify the effect of altitude on iron bioavailability from a potato meal consumed over 5 consecutive days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedStudy Start
First participant enrolled
August 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedApril 17, 2024
April 1, 2024
6 months
July 11, 2022
April 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Iron absorption
Iron absorption will be assessed by measuring the shift in the iron isotopic composition in red blood cells, 14 days after the last test meal administration. Iron absoroption will be expressed as percentage of the total dose administered in the test meals (%)
3 weeks
Secondary Outcomes (4)
Serum ferritin (SF)
5 minutes (combined with other biochemical assessements)
soluble transferrin receptor (sTfR)
5 minutes (combined with other biochemical assessements)
C-Reactive Protein (CRP)
5 minutes (combined with other biochemical assessements)
alpha acid glycoprotein (AGP)
5 minutes (combined with other biochemical assessements)
Other Outcomes (3)
Socioeconomic, diet and physical activity
1 hour
Erytropoietin
5 minutes (combined with other biochemical assessements)
Erythroferrone
5 minutes (combined with other biochemical assessements)
Study Arms (1)
Biofortified potato
EXPERIMENTAL500 g of biofortified, cooked potato, comsumed over 5 consecutive days (500g for each day, for a total of 2500 g of cooked potato). Potato meals will be labelled with a total of 3 mg 57FeSO4.
Interventions
Cooked potato, not genetically modified, with the addition of an acqueous solution of 57FeSO4 (3 mg in total).
Eligibility Criteria
You may qualify if:
- Healthy women aged 18-40 years
- Able to understand study requirements and provide written informed consent.
- Huancavelica study site: having been a Huancavelica or Peruvian highlands resident in the last 5 years, with at least one parent being from Huancavelica
- Lima study site: having been a Lima resident in the last 5 years, with origins and at least one parent being from the Peruvian highlands (\>3000 masl)
- Serum ferritin at screening \< 30 microgram/L
You may not qualify if:
- Illness that affects the nutritional status or food intake: gastrointestinal or renal problems; self-reported metabolic disease based on prior diagnosis, or a prior screening questionnaire.
- Pregnancy (positive urine test).
- Currently breastfeeding.
- Allergy to any ingredients of the test meal.
- C-reactive protein \>5mg/100ml (representing inflammation)
- Smoker (\>1 cigarette per day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Instituto International Nutrition
Huancavelica, Peru
Insituto National de Nutrition
Lima, Peru
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diego Moretti, PhD
Swiss Distance University of Applied Sciences
- STUDY DIRECTOR
Maria-Reyna Liria, PhD
Insituto Investigation Nutritional
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2022
First Posted
August 12, 2022
Study Start
August 20, 2022
Primary Completion
February 1, 2023
Study Completion
April 30, 2024
Last Updated
April 17, 2024
Record last verified: 2024-04